Aligos Therapeutics GAAP EPS of -$1.91 beats by $0.12
Source: SeekingAlpha
2026-03-05 13:02:25 ET
More on Aligos Therapeutics
- Seeking Alpha’s Quant Rating on Aligos Therapeutics
- Historical earnings data for Aligos Therapeutics
- Financial information for Aligos Therapeutics
Read the full article on Seeking Alpha
For further details see:
Aligos Therapeutics GAAP EPS of -$1.91 beats by $0.12
Aligos Therapeutics Inc.
NASDAQ: ALGS
ALGS Trading
2.07% G/L:
$7.165 Last:
17,339 Volume:
$6.92 Open:
ALGS Latest News
March 05, 2026 08:00:00 am
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 08:00:00 am
Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
February 23, 2026 08:00:00 am
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
ALGS Stock Data
$44,428,862
3,138,388
3.86%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
